NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 38 filers reported holding NIVALIS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $310,000 | -37.0% | 128,800 | -23.6% | 0.02% | -38.7% |
| Q1 2017 | $492,000 | +794.5% | 168,580 | +579.8% | 0.03% | +520.0% |
| Q4 2016 | $55,000 | -62.1% | 24,800 | +38.5% | 0.01% | -58.3% |
| Q3 2016 | $145,000 | -56.3% | 17,900 | -58.4% | 0.01% | -71.4% |
| Q4 2015 | $332,000 | +16.1% | 43,000 | +95.5% | 0.04% | +13.5% |
| Q3 2015 | $286,000 | – | 22,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|